Galapagos NV: business update: http://t.co/6w1jppWE
posted 5 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Ablynx [Euronext Brussels: ABLX] today announced that its Chief Scientific Officer, Debbie Law, has resigned from her position at Ablynx, effective 31 August, as she will be returning to the USA with her family for personal reasons.
The Ablynx senior management will work closely to ensure continuity of scientific strategy and progress until a replacement for Dr. Law has been identified.
"It has been a pleasure working with Debbie who brought great knowledge, biologics experience and passion to Ablynx. We thank Debbie for her accomplishments and commitment to Ablynx and greatly appreciate all she has done to help us develop Ablynx into what we believe is one of the most advanced independent, next generation biologics companies. We wish her the best of luck in returning to the USA," said Dr. Edwin Moses, Chairman and Chief Executive Officer.
Source: Ablynx
Tags: management
Bookmark this:
